FRIDAY, Dec. 27, 2024 (HealthDay News) A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn’s disease. A new study published recently in the journal Gut shows children with Crohn’s who were prescribed anti-TNF (tumor necrosis factor) drugs following their diagnosis had an 82% lowerContinue Reading

THURSDAY, Dec. 26, (2024 HealthDay News)  — The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes. Liraglutide, the generic for Victoza, is similar to semaglutide, the active ingredient inContinue Reading